Posted September 17, 2019
Yan Y, Serra V, Prudkin L, Scaltriti M, Murli S, Rodríguez O, Guzman M,Sampath D, Nannini M, Xiao Y, Wagle MC, Wu JQ, Wongchenko M, Hampton G, Ramakrishnan V, Lackner MR, Saura C, Roda D, Cervantes A, Tabernero J, Patel P, Baselga J. Evaluation and Clinical Analyses of Downstream Targets of the Akt Inhibitor GDC-0068. Clin Cancer Res. 2013 Dec 15;19(24):6976-86.